The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats Authors: Masoume Akhbari, Fatemeh Babaei, Ava Navidi-Moghaddam, Shiva Ghafghazi, Fatemeh Khodabandehloo, Mohammad Reza Sarookhani, Leila Dargahi, Ghazaleh Mohammadi, Marjan Nassiri-Asl Published: 2026 ABSTRACT Saccharomyces boulardii (Sb), a probiotic yeast, is known for its positive effects on gastrointestinal and metabolic health. Recent research has explored its potential to influence neurological conditions by modulating neuroinflammatory responses via the gut-brain axis. Toll-like receptor 4 (TLR4) is recognized as a key molecular target in regulating neuroinflammation, particularly in disorders like Alzheimer’s disease (AD). This study investigated whether Sb could alleviate downstream elements of the TLR4 neuroinflammatory pathway in a lipopolysaccharide (LPS)-induced rat model relevant to AD. Rats were randomly assigned to four groups: 1) control, 2) LPS, 3) Sb + LPS, and 4) Sb alone. All groups received either normal saline or Sb (a volume of 1 ml containing 10 ¹⁰ CFU) by oral gavage for four weeks. From day 14, LPS (250 μg/kg/day) or saline was administered intraperitoneally for nine days. Researchers assessed spatial memory, levels of TLR4 pathway-associated proteins in the hippocampus, pro-inflammatory cytokine expression, and neuronal survival using Nissl staining. The results showed that pre-treatment with Sb partially ameliorated spatial learning deficits, significantly reducing the LPS-induced elevation of nuclear factor kappa B (NF-κB) and interleukin-1β (IL-1β) in the hippocampus and protecting against neuronal loss in the hippocampal CA1 region. Sb mitigates LPS-induced neuroinflammation by modulating downstream elements of the TLR4 pathway—specifically NF-κB and IL-1β—rather than acting directly on the TLR4 receptor, likely through mechanisms involving the gut-brain axis. Introduction An imbalance in gut microbiota composition, known as dysbiosis, has been linked to the regulation of key mechanisms involved in Alzheimer's disease (AD), such as neuroinflammation, blood-brain barrier (BBB) function, and neurotransmitter control (Inan et al., 2025, Yang et al., 2024). Recent research suggests that the gut microbiota composition can affect aging-related changes via the gut-brain axis. A major pathway involves chronic systemic inflammation caused by dysbiosis, leading to BBB disruption and activation of neuroinflammatory processes (Olejnik, et al., 2025). In particular, gut-derived neurotoxic metabolites like lipopolysaccharide (LPS) have been implicated in triggering neuroinflammation either by directly crossing the BBB or by stimulating the production of inflammatory cytokines within the brain (Jiang et al., 2017, Suganya and Koo, 2020). Gut microbiota imbalances may affect cognitive performance in aging and activate the LPS-triggered Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway, leading to neuroinflammatory responses in the brain(Magistrelli et al., 2019;Tankou et al., 2018). Recent studies emphasize the therapeutic potential of modulating the gut microbiota with probiotics—live microorganisms that confer health benefits to the host—in preventing or attenuating neuroinflammation and neurodegeneration (Magistrelli et al., 2019, Mohammadi et al., 2019a, Tankou et al., 2018). Among these, the yeast probiotic Saccharomyces boulardii has demonstrated anti-inflammatory properties in several models of inflammatory disease (Babaei et al., 2022b, Sarkar et al., 2021, Tao et al., 2021). However, the mechanisms by which S. boulardii exerts neuroprotective effects, particularly in the context of TLR4-mediated neuroinflammation, remain to be fully elucidated. This study aims to investigate the impact of S. boulardii on neuroinflammatory processes and cognitive function in an LPS-induced model of neuroinflammation relevant to AD. Specifically, we focus on the modulation of TLR4/NF-κB signaling, pro-inflammatory cytokine expression, and neuronal survival within the hippocampal CA1, CA2, and CA3 regions—areas known to be particularly vulnerable in AD (Liang et al., 2020, Padurariu et al., 2012). Spatial memory performance is assessed using the Morris water maze (MWM), a standard test for evaluating cognitive deficits in animal models of AD (Samal et al., 2019). Protein levels of interleukin−1β (IL−1β), tumor necrosis factor-α (TNF-α), and brain-derived neurotrophic factor (BDNF) were assessed in the hippocampus. We hypothesize that S. boulardii administration will attenuate downstream effectors of the hippocampal TLR4 neuroinflammatory pathway, promote neuronal survival, and improve spatial memory in this model. Materials and methods Animals Adult male Wistar rats, weighing 200–250 g, were maintained in a colony room at Shahid Beheshti University of Medical Sciences. They were subjected to a light/dark cycle of 12 h each and were kept at a constant room temperature of 21 ± 2 °C, with unrestricted access to food and water. All experiments were approved by the Ethics Committee of Qazvin University of Medical Sciences (IR.QUMS.REC 1399.562) and performed according to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. Experimental design A total of 40 rats were randomly divided into four equal groups of 10. The control group was treated with saline via both oral gavage and i.p. injection. The LPS group received saline by gavage and LPS by i.p. injection, while the Sb group was administered S. boulardii via gavage and saline via i.p. injection. The Sb + LPS group received S. boulardii via gavage and LPS via i.p. injection. Oral doses of either saline or S. boulardii (250 mg) were provided for 28 days. Furthermore, LPS (250 μg/kg/day, i.p.) was administered for nine consecutive days (days 14–22), following the protocol of (Babaei et al., 2022b). The animals were subjected to the Morris Water Maze (MWM) test, which consisted of four consecutive days of the training phase (days 24–27) followed by the probe test on the subsequent day (day 28). After completing the MWM task, six rats were randomly sacrificed under deep anesthesia with ketamine/ xylazine. The hippocampi were swiftly removed and stored at –80°C. To ensure the stability of proteins in our samples, their expression was analyzed using the western blotting technique after 48. Four animals in each group were sacrificed for histological assays (Workflow in Fig. 1). This involved brain removal following perfusion with PBS and 4% paraformaldehyde.Fig. 1Workflow of experimental procedures. Workflow of experimental procedures. Drugs This investigation has used the commercial probiotic DAILYEAST® capsule (Zist Takhmir Company, Tehran, Iran) and LPS (Escherichia coli 055:B5, Sigma) as treatments. The active yeast S. boulardii was present in each probiotic capsule at a dosage of 250 mg (1010 colony-forming units [CFU]. Before administration, 0.9% NaCl and phosphate-buffered saline (PBS) were employed for dissolving probiotic and LPS, respectively. Morris water maze task The Morris Water Maze (MWM) task was performed from days 23–28 to evaluate spatial learning and long-term memory. The apparatus consisted of a black cylindrical tank (150 cm diameter × 70 cm height) filled with water (22 ± 2 °C), conceptually divided into four equal quadrants. A circular platform (10 cm diameter) was submerged 1–1.5 cm below the water surface in the center of the target quadrant. Distinct visual cues were fixed on the walls surrounding the tank to facilitate spatial navigation. Rat performance was recorded via a digital camera (Panasonic Inc., Japan) and analyzed using EthoVision software (version XT7.1, Netherlands). During the training sessions, rats underwent four trials daily at 10-min intervals (Chavoshinezhad et al., 2019). In each trial, the rat was placed in the water facing the tank wall and given 60 s to locate the hidden platform. If the rat failed to reach the platform within this time, it was gently guided to the platform and allowed to remain there for 20 s. Escape latency, defined as the time required to reach the platform, was recorded as the primary metric for spatial learning. Twenty-four hours after the final training trial, a probe session was conducted to assess memory retention. The platform was removed, and each rat was placed in the quadrant opposite the target and allowed to swim freely for 60 s. During this session, the latency to the first crossing of the former platform site, the time spent in the target quadrant, and the total distance traveled were recorded as indicators of long-term spatial memory. Finally, one hour after the probe session, a visible platform covered with aluminum foil was placed above the water surface in the quadrant opposite the original target. Rats performed four trials identical to the training protocol to assess their visuo-motor performance. Western blotting analysis Protein levels of TNF-α, IL−1β, BDNF, TLR4, and NF-κB in hippocampal tissue were evaluated using western blot analysis. The first step was conducted by homogenizing samples in a lysis buffer via a micro homogenizer at 3000 rpm and 4 °C. Protein extractions were obtained from supernatants after centrifugation of tissue lysates at 12000 rpm (20 min at 4 °C). The Bradford method was then utilized to measure the protein concentration. Following this, 20 μg of protein samples were loaded onto a 12% SDS gel for electrophoresis, and subsequently, they were transferred to polyvinylidene difluoride (PVDF) membranes. The blots were then blocked with 5% bovine serum albumin in Tris-buffered saline containing 0.1% Tween 20 for 1 h at room temperature and incubated with antibodies, including anti-IL−1β (1:1000, ab254360, Abcam), anti-TNF-α (1:1000, ab205587, Abcam), anti-TLR4 (1:1000, ab217274, Abcam), anti- NF-κB p65 (2μg/ml, NB100–56712, NOVUS) and anti-BDNF (1:1000, ab108319, Abcam) overnight at 4 ゜C. The membranes were rinsed and exposed to secondary antibody for 1 h at room temperature. Ultimately, the protein bands were visualized using an ECL detection system (Bio-Rad). ImageJ software quantified the density of protein bands, and the expression was normalized using β-actin (1:2500, ab8227, Abcam). Histological assay Nissl staining was used to study neuron counts in various hippocampus regions. For this purpose, paraffin-embedded coronal sections with a thickness of 7 µm were deparaffinized in xylene, rehydrated through decreasing percentages of ethanol and water, and then exposed to a 0.1% Cresyl Violet solution (Sigma, Germany) for 4 min at 60°C. The slices were subsequently rinsed in distilled water, dehydrated using increasing concentrations of ethanol, cleaned in xylene, cover-slipped with mounting medium, and observed under a microscope (Eclipse E600, Nikon). Using ImageJ software, neuronal density was quantified in the CA1, CA2, and CA3 subfields of the hippocampus. Quantification was performed on three randomly selected histological sections per animal, spaced at least 50 µm apart, corresponding to levels between 3.2 and 3.7 mm posterior to bregma. In each hippocampal subfield, neurons were counted in three non-overlapping fields acquired at × 40 magnification. Mean values were calculated for each animal, normalized to the control group, and expressed as percentages. Statistical analysis Differences between trials within groups were analyzed by repeated measures of two-way analysis of variance (ANOVA). The difference between treatment groups within trials and the parameters of probe session, western blot, and histology were analyzed by one-way ANOVA followed by the Tukey-Kramer test in GraphPad Prism. The results were expressed as mean ± standard error of the mean (SEM). P value < 0.05 was considered a significant level to express the difference between groups. Results The effect of S. boulardii administration on spatial learning and memory Two-way repeated measure ANOVA for MWM data indicated a significant main effect of treatment, F (3, 34) = 3.868; P = 0.0175, and days, F (3, 102) = 140.2; P < 0.0001 on the escape latency in training days 1–4. Based on the intergroup analysis, the LPS group exhibited significantly longer escape latency in comparison to the control group on training days 3–4 (Fig. 2a; P = 0.0111 and P = 0.0019, respectively). Additionally, the findings demonstrated that the administration of S. boulardii significantly reduced the escape latency of the Sb + LPS group in comparison to the LPS group on days 3–4 (Fig. 2a; P = 0.0214 and P = 0.0050, respectively).Fig. 2The effect of S. boulardii administration (gavage, four weeks, 1010 CFU/rat/day) on spatial learning and memory in LPS-induced (250 µg/kg/day, i.p., for 9 days), rats. a) Escape latency to locate the concealed platform during four consecutive days, b) The latency to first cross the former platform location in the probe trial. c) Distance moved to reach the platform. (d) The duration of time spent in target quadrant; (e) The escape latency to locate the visible platform during visio-motor activity. Data are presented as the mean ± SEM. The differences between groups were identified by ANOVA and Tukey test. n = 9–10, *P < 0.05 and **P < 0.01 vs. the control and the LPS groups. The effect of S. boulardii administration (gavage, four weeks, 1010 CFU/rat/day) on spatial learning and memory in LPS-induced (250 µg/kg/day, i.p., for 9 days), rats. a) Escape latency to locate the concealed platform during four consecutive days, b) The latency to first cross the former platform location in the probe trial. c) Distance moved to reach the platform. (d) The duration of time spent in target quadrant; (e) The escape latency to locate the visible platform during visio-motor activity. Data are presented as the mean ± SEM. The differences between groups were identified by ANOVA and Tukey test. n = 9–10, *P < 0.05 and **P < 0.01 vs. the control and the LPS groups. During the probe test, as depicted in Fig. 2b and c, one-way ANOVA analysis indicated a significant increase in escape latency and the total distance moved in the LPS group compared to the control group (Fig. 2b and c; P = 0.0082, P = 0.0013, respectively). Administration of S. boulardii did not statistically decrease escape latency and total distance in Sb + LPS group compared to the LPS group (Fig. 2b and c). In the probe test, the LPS group exhibited a significantly reduced time in the target quadrant compared to the control group (Fig. 2d; P = 0.0141). Administration of S. boulardii did not significantly increase time in the target quadrant in Sb + LPS group compared to the LPS group (Fig. 2d). In the assessment of the vision test, as expected, there was no statistically significant difference in the escape latency (Fig. 2e). The effect of S. boulardii administration on hippocampal BDNF expression and downstream effectors within the TLR4 neuroinflammatory signaling pathway and hippocampal inflammatory cytokines LPS suppressed BNDF expression in the hippocampus (Fig. 3a; P = 0.0195). S. boulardii pre-treatment did not significantly decrease LPS-dependent suppression of BDNF expression compared to LPS alone. LPS administration led to a significant elevation in the expression levels of TLR4, NF-κB, IL−1β, and TNF-α compared to the control group (P = 0.0035, P = 0.0028, P = 0.0023, P = 0.0088, respectively), indicating neuroinflammatory response following LPS induction. Pretreatment with S. boulardii significantly reduced LPS-induced elevated hippocampal NF-κB and IL−1β expression levels in Sb + LPS groups (Fig. 3c; P = 0.0310 and Fig. 3d; P = 0.0048, respectively), but not for TLR4 and TNF-α (Fig. 3b and e), in Sb + LPS groups compared to LPS groups.Fig. 3The effect of S. boulardii (gavage, four weeks, 1010 CFU/rat/day) on downstream effectors within the TLR4 neuroinflammatory signaling pathway and hippocampal inflammatory cytokines in LPS-stimulated (250 µg/kg/day, i.p., for 9 days) rats. Representative immunoblot bands and quantitative analysis of BDNF, TLR4, NF-κB, TNF-α, and IL−1β expression in rat hippocampi (a, b, c, and d, respectively). The level of proteins was measured relative to β-actin. The quantitative results are expressed as normalized optical density relative to the control group. Data are presented as the mean ± SEM. n = 3–4, *P < 0.05, and **P < 0.01 vs. control and LPS groups. The effect of S. boulardii (gavage, four weeks, 1010 CFU/rat/day) on downstream effectors within the TLR4 neuroinflammatory signaling pathway and hippocampal inflammatory cytokines in LPS-stimulated (250 µg/kg/day, i.p., for 9 days) rats. Representative immunoblot bands and quantitative analysis of BDNF, TLR4, NF-κB, TNF-α, and IL−1β expression in rat hippocampi (a, b, c, and d, respectively). The level of proteins was measured relative to β-actin. The quantitative results are expressed as normalized optical density relative to the control group. Data are presented as the mean ± SEM. n = 3–4, *P < 0.05, and **P < 0.01 vs. control and LPS groups. The effect of S. boulardii administration on hippocampal neuronal loss induced by LPS Cresyl violet staining was used to quantify surviving neurons across hippocampal subfields. LPS administration led to a significant reduction in the percentage of surviving neurons in the CA1, CA2, and CA3 regions compared with the control group (Fig. 4b; P = 0.0002, 0.0098, 0.0178, respectively). Pretreatment with S. boulardii in Sb + LPS group significantly increased neuronal survival in CA1 subfield relative to the LPS group (Fig. 4b, P = 0.0032). In contrast, the percentage of surviving neurons in the CA2 subfield of the Sb + LPS group remained significantly different from that of the control group (Fig. 4b, P = 0.0302).Fig. 4The effect of S. boulardii (gavage, four weeks, 1010 CFU/rat/day) pretreatment on LPS-induced (250 µg/kg/day, i.p., for 9 days) neuronal loss in the hippocampus. a) Representative images of Nissl-stained hippocampus sections at × 4 and 40 magnification. Morphological evaluation shows fewer and sparsely distributed neurons in the CA1, CA2, and CA3 subfields of the hippocampus in the LPS group. b) Neuronal density represented on the graphs per hippocampal subfield. Significant increases in the number of alive neurons in the CA1 and CA3 are observed in SB + LPS group. Data are presented as mean ± SEM. n = 3–4, *P < 0.05,**P < 0.01, ***P < 0.001 vs. control and LPS groups. The effect of S. boulardii (gavage, four weeks, 1010 CFU/rat/day) pretreatment on LPS-induced (250 µg/kg/day, i.p., for 9 days) neuronal loss in the hippocampus. a) Representative images of Nissl-stained hippocampus sections at × 4 and 40 magnification. Morphological evaluation shows fewer and sparsely distributed neurons in the CA1, CA2, and CA3 subfields of the hippocampus in the LPS group. b) Neuronal density represented on the graphs per hippocampal subfield. Significant increases in the number of alive neurons in the CA1 and CA3 are observed in SB + LPS group. Data are presented as mean ± SEM. n = 3–4, *P < 0.05,**P < 0.01, ***P < 0.001 vs. control and LPS groups. Discussion Our findings demonstrate that LPS administration significantly impaired spatial learning and memory in rats, as evidenced by increased escape latency during training and reduced performance during the probe test. Specifically, LPS-treated rats showed a decreased preference for the target quadrant and increased search distances, indicating a deficit in spatial navigation and memory retention. Interestingly, the administration of S. boulardii exerted a protective effect on spatial learning, as shown by a significant reduction in escape latency during the later training days (days 3–4) in the Sb + LPS group compared to the LPS-only group. However, this recovery was not fully mirrored in the probe test, where S. boulardii did not significantly reverse the memory deficits induced by LPS. The lack of significant differences in the visible platform test confirms that the observed cognitive impairments were not due to visual or motor deficits, but rather to neurocognitive dysfunction induced by LPS, which S. boulardii appears to partially mitigate during the acquisition phase of learning. This investigation focused on modulating downstream effectors of the hippocampal TLR4 neuroinflammatory pathway via the gut-brain axis. We utilized a systemic LPS administration model to simulate neuroinflammation relevant to AD. Neuroinflammation is a primary molecular event that initiates or accelerates neurodegeneration in many disorders, including AD (Leng and Edison, 2021). Microglia play a vital role in mediating this inflammatory response (Muzio et al., 2021). Prolonged microglial activation leads to the hyperproduction of cytokines, including TNF-α, IL−1β, and IL−6, which drive neurodegeneration, particularly within the hippocampus (Wang et al., 2023, Wang et al., 2015). Activation of TLR4 signaling following systemic LPS injection increases the levels of neurotoxic inflammatory mediators, leading to memory and cognitive decline (Ali et al., 2024, da Silva et al., 2024). Consistently, our results revealed that LPS stimulation activates the TLR4/NF-κB pathway, resulting in neuroinflammation characterized by a substantial increase in hippocampal IL−1β and TNF-α protein levels. Probiotic supplementation has been shown to ameliorate neuroinflammation by modulating these cytokine levels (Song et al., 2022). Manipulation of the gut microbiota with S. boulardii has been shown to mitigate neuroinflammatory responses by diminishing hippocampal levels of TNF-α, IL−1β, and monocyte chemoattractant protein−1 (MCP−1), ultimately reducing neuronal damage and improving memory deficits (Sarkar et al., 2021). Similarly, Ye et al. (2022) suggested that S. boulardii can impede microglial-induced neuroinflammation via the TLR pathway, reducing IL−6, IL−1β, and cluster of differentiation 11b (CD11b) expression in the cerebral cortex of transgenic (Tg) mice (Ye et al., 2022). Our results demonstrate that prophylactic administration of S. boulardii reduces hippocampal IL−1β levels, likely by modulating downstream effectors of the TLR4 pathway. LPS triggers the CD14/TLR4/MD2 receptor complex, initiating MyD88-dependent signaling cascades that activate MAPK proteins and the translocation of NF-κB (Scott and Billiar, 2008). The MyD88-dependent pathway induces the expression of gene-coding pro-inflammatory mediators, such as TNF-α, IL−6, and cyclooxygenase 2 (Ciesielska et al., 2021). Furthermore, the engagement of MAPK signaling pathways—comprising extracellular signal-related kinase (ERK) 1/2, p38 MAPK, and c-Jun N-terminal kinase (JNK)—is well-established in inflammatory responses (Koga et al., 2019). The phosphorylation of MAP kinases activates the transcription factors cAMP response element-binding protein (CREB), and activator protein 1 (AP−1) (Ciesielska et al., 2021). Given S. boulardii’s effect on NF-κB and TNF-α in the Sb + LPS group, it is important to recognize that LPS can also induce TNF-α and IL−6 production via the MAPK pathway. S. boulardii CNCMI−745 has demonstrated the capacity to inhibit TLRs/MyD88/NF-κB/MAPK signaling pathways in the gut, concurrently diminishing both mRNA and protein concentrations of pro-inflammatory factors (Justino et al., 2020). Furthermore, NLRP3 inflammasome activation by LPS occurs via both canonical (TLR4/NF-κB) and non-canonical signaling pathways (Barker and Weiss, 2019, Ciesielska et al., 2021). The initiation of NLRP3 and subsequent activation of caspase−1 transform cytokine precursors into active IL−1β (Wang et al., 2020). In previous work, we demonstrated that S. boulardii pretreatment prevented the upregulation of hippocampal NLRP3 and caspase−1 (Babaei et al., 2022a). In the current study, S. boulardii also reduced NF-κB expression. Thus, the inhibitory effect of S. boulardii may extend to the NLRP3 inflammasome through both canonical and non-canonical pathways. Further experiments are required to identify the specific downstream regulatory pathways governing this cytokine production. As noted, systemic LPS injection induces memory deficit and a decline in learning ability, like in AD. S. boulardii consumption has alleviated cognitive impairment by LPS in the novel recognition task and memory retrieval in rats (Babaei et al., 2022a, Mohammadi et al., 2024). While our results indicated that S. boulardii improved performance during the learning phase, it did not produce a statistically significant improvement in the memory probe test compared to the LPS group, although a positive trend was observed. Consistent with our finding, Sarkar et al. (2021) suggested that S. boulardii ameliorates spatial memory impairment induced by antibiotics in mice (Sarkar et al., 2021). Because neurodegeneration—marked by synaptic damage and neuronal loss—is a primary cause of cognitive impairment in AD (Crews and Masliah, 2010), we assessed neuronal changes in the hippocampus. We observed significant neuronal loss in the hippocampus's cornus ammonis (CA) subfields following LPS-induced neuroinflammation. Conversely, S. boulardii pretreatment preserved neuronal density in the CA1 region, consistent with findings by Sarkar et al. (2021) and Yang et al. (2020), who demonstrated that probiotics protect hippocampal neurons by suppressing TLR4-mediated NF-κB pathways (Sarkar et al., 2021, Yang et al., 2020). BDNF is well-documented to be reduced in both the brain and blood of patients with AD (Leyhe et al., 2008, Ng et al., 2019), a finding consistently mirrored in various AD-like animal models A reduction in BDNF has also been observed in the CNS or serum of various AD-like mouse models (Garcez et al., 2017, Kar et al., 2022, Luo et al., 2019). Our study similarly observed a decline in hippocampal BDNF protein levels following systemic LPS administration. While several studies have reported that probiotic interventions—such as Lactobacillus helveticus and Bifidobacterium longum—can rescue memory deficits by upregulating hippocampal BDNF in LPS-challenged rats (Mohammadi et al., 2019b), or that B. bifidum BGN4 and B. longum BORI can boost BDNF in 5xFAD mice (Kim et al., 2021), the relationship between probiotics and BDNF remains complex. For instance, L. gasseri has been shown to improve cognition in LPS-treated mice by promoting BDNF expression (Yun et al., 2023); however, other investigations have reported that probiotic supplementation does not always result in significant elevations of BDNF in either human or animal subjects (Babaei et al., 2022b, Schneider et al., 2023). Our findings revealed that S. boulardii did not lead to a significant increase in BDNF protein levels. This implies that while S. boulardii may not restore BDNF, it still provides neuroprotective benefits by mitigating neuroinflammation and improving cognitive acquisition. In conclusion, our results support the notion that S. boulardii reduces LPS-induced neuroinflammation and memory deficits by influencing downstream effectors of the hippocampal TLR4 neuroinflammatory pathway. Limitations This study has several limitations. The neuroprotective effects of S. boulardii demonstrated here are strain-specific and may not represent the action of other probiotics. Additionally, using only male rats limits the translation of these results to females, who suffer disproportionately from certain neurological conditions. Methodologically, the acute LPS model may not fully mirror chronic neurodegeneration, and the small sample size for Western blotting (n = 3 −4) restricts the statistical power of our molecular analyses. Finally, the non-significant differences observed in upstream markers (TLR4, TNF-α) and MWM probe trials suggest that the therapeutic mechanisms and overall effect sizes are highly complex and require further investigation. Conclusion This study assessed the influence of pretreatment of S. boulardii on downstream effectors of the hippocampal TLR4 neuroinflammatory pathway within the hippocampus in rats exposed to LPS. The key findings suggest that pre-treatment with S. boulardii partially ameliorates spatial learning deficits, significantly reduces the LPS-induced elevation of NF-κB and IL−1β, and protects against neuronal loss in the CA1 and CA3 regions of the hippocampus. The findings suggested that prophylactic S. boulardii can alleviate neuroinflammation induced by LPS, reduce neuronal loss, and improve subsequent memory deficit by regulating the downstream effectors of the hippocampal TLR4 neuroinflammatory pathway. In summary, our results proposed that oral administration of S. boulardii could be a beneficial strategy to alleviate neuroinflammation and its related detrimental effects by influencing the gut-brain axis. Identifying pivotal targets influenced by S. boulardii's modulatory effects on cytokine production holds substantial promise for better management of neuroinflammatory diseases, including AD. However, additional investigations are necessary to confirm and expand upon these findings. Foundation The Vice Chancellor of Research at 10.13039/501100006396Qazvin University of Medical Sciences supported this work (Grant No: 28.20.18351). CRediT authorship contribution statement Marjan Nassiri-Asl: Writing – review & editing, Validation, Supervision, Resources, Project administration, Methodology, Funding acquisition, Formal analysis, Data curation, Conceptualization. Ghazaleh Mohammadi: Writing – review & editing, Supervision, Methodology, Formal analysis, Data curation, Conceptualization. Leila Dargahi: Writing – review & editing, Validation, Methodology, Data curation. Mohammad Reza Sarookhani: Writing – review & editing, Methodology. Masoume Akhbari: Writing – original draft, Visualization, Investigation, Formal analysis, Data curation. Fatemeh Khodabandehloo: Writing – review & editing, Investigation, Data curation. Fatemeh Babaei: Writing – review & editing, Investigation. Shiva Ghafghazi: Writing – review & editing, Investigation. Ava Navidi-Moghaddam: Writing – review & editing, Investigation. Conflicts of Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.